Arixtra Injection, Solution
Product Images NDC 67457-594

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Arixtra (NDC 67457-594). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 And 2 (Image 01)

FDA Label Image

Figure 3 And 4 (Image 02)

FDA Label Image

Fondaparinux Sodium Structural Formula (Image 03)

FDA Label Image

Arixtra-syringe-1 (Image 04)

FDA Label Image

Arixtra-syringe-2 (Image 05)

FDA Label Image

Arixtra-syringe-3 (Image 06)

FDA Label Image

Arixtra-figure-a (Image 07)

FDA Label Image

Arixtra-figure-b (Image 08)

FDA Label Image

Arixtra-figure-c (Image 09)

FDA Label Image

Arixtra-figure-d (Image 10)

FDA Label Image

Arixtra-figure-e (Image 11)

FDA Label Image

Arixtra-figure-f (Image 12)

FDA Label Image

Arixtra Injection 2.5 mg/0.5 mL Carton Label (Image 13)

This is a product description of a medication called fondaparinux sodium injection, USP, used for subcutaneous injection. This medication contains 10 single-dose prefilled syringes with an automatic needle protection system. The text also includes a warning for the pharmacist to dispense the accompanying patient information leaflet to each patient. The rest of the text appears to contain code numbers and irrelevant characters.*

FDA Label Image

Arixtra Injection 5 mg/0.4 mL Carton Label (Image 14)

FDA Label Image

Arixtra Injection 7.5 mg/0.6 mL Carton Label (Image 15)

This is a description of a medication named "Fondaparinux Sodium Injection, USP", indicated for subcutaneous injection and being sold in a package containing 10 prefilled syringes with an automatic needle protection system. The package's lot number and expiration date can be found on it. There is also a recommendation for storing the medication at room temperature (20°C to 25°C) and for dispensing a patient information leaflet to each patient. The rest of the text is not legible.*

FDA Label Image

Arixtra Injection 10 mg/0.8 mL Carton Label (Image 16)

This text appears to be a label for a medication called Fondaparinux Sodium Injection, prescribed for subcutaneous injection. The label includes dosage information (0°C BEF to 8 893 USP Corfrolid Foom Temperstre), instructions for pharmacists (to dispense patient information leaflets), and details about the packaging (10 single-dose, prefilled syringes with an automatic needle protection system). It also includes the NDC code (67467-595-08) for the medication as well as manufacturer information (Mylan) and lot and expiration details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.